{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:10:17Z","timestamp":1784826617000,"version":"3.55.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Bayesian area under the curve (AUC)\u2013guided vancomycin dosing, preferably with 2 samples (2S), is recommended for pediatric patients. However, the timing of sampling may not always be convenient in the clinical setting. In low- to middle-income countries, the implementation of model-informed precision dosing (MIPD) using the Bayesian approach remains limited because of high software costs. Using MIPD with Bayesian analysis, the authors compared the accuracy and precision of midpoint and guideline-recommended 2S strategies and evaluated the clinical utility of an open-source software package and compared it with PrecisePK.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective cohort study was conducted at 2 pediatric hospitals with a combined 2000 beds from April 2022 to April 2023. The authors enrolled patients aged from 3 months to 16 years who received at least 2 doses of vancomycin and had at least 2 measured drug concentrations: <jats:italic toggle=\"yes\">C<\/jats:italic>\n                                 <jats:sub>max<\/jats:sub> (1\u20132 hours after the end of infusion), <jats:italic toggle=\"yes\">C<\/jats:italic>\n                                 <jats:sub>mid<\/jats:sub> (midpoint of the dosing interval), and <jats:italic toggle=\"yes\">C<\/jats:italic>\n                                 <jats:sub>trough<\/jats:sub> (30 minutes\u20131 hour before the next dose). The accuracy and precision of pharmacokinetic parameters were calculated using \n                                    \n                                       \n                                    \n                                  and \n                                    \n                                       \n                                    \n                                 , respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eighty children with 226 vancomycin concentrations were included. The median age was 1.6 (interquartile range 0.88\u20133.01) years, the average weight was 10.0 (8.0\u201312.0) kg, the baseline serum creatinine concentration was 0.43 (0.38\u20130.53) mg\/dL, and the empirical vancomycin dose was 60 (57\u201361) mg\/kg\/d. Most subjects received empirical vancomycin for pneumonia (75%) and bacteremia (26%), and 75% were admitted to the intensive care unit. Compared with the 2S monitoring state, the accuracy and precision of the midpoint for the Bayesian-derived AUC<jats:sub>24<\/jats:sub> values were 5.02% and 6.45%, respectively. Compared with PrecisePK, the AUC<jats:sub>24<\/jats:sub> estimation by Shiny exhibited an accuracy and precision of \u22125.58% and 6.09%, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Midpoint concentration offers a convenient sampling approach to accurately monitor vancomycin therapy in hospitalized pediatric patients. Shiny serves as an alternative Bayesian MIPD tool for dosing and monitoring vancomycin therapy in children in Vietnam.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001323","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T14:54:35Z","timestamp":1743346475000},"page":"603-608","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Model-Informed Precision Dosing of Vancomycin in Vietnamese Children: Innovative Midpoint Concentration Monitoring Using 2 Bayesian Programs"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3301-1374","authenticated-orcid":false,"given":"Ba","family":"Hai Le","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Hanoi University of Pharmacy, Hanoi, Vietnam;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Kien","family":"Phung","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Hanoi University of Pharmacy, Hanoi, Vietnam;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Yip","sequence":"additional","affiliation":[{"name":"University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjum","family":"Gupta","sequence":"additional","affiliation":[{"name":"PrecisePK, San Diego, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Linh","family":"Phan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Hanoi University of Pharmacy, Hanoi, Vietnam;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lai","sequence":"additional","affiliation":[{"name":"University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Hoang","sequence":"additional","affiliation":[{"name":"University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Hai","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Hanoi University of Pharmacy, Hanoi, Vietnam;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Dua","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Saint Paul Hospital, Hanoi, Vietnam; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Thao","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Thanh Hoa Pediatric Hospital, Thanh Hoa, Vietnam."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Lien Huong","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Hanoi University of Pharmacy, Hanoi, Vietnam;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6692-0884","authenticated-orcid":false,"given":"Jennifer","family":"Le","sequence":"additional","affiliation":[{"name":"University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"R1-20250912","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"R2-20250912","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/FTD.0000000000000910","article-title":"Implementation of vancomycin therapeutic monitoring guidelines: focus on Bayesian estimation tools in neonatal and pediatric patients","volume":"44","author":"Han","year":"2022","journal-title":"Ther Drug Monit"},{"issue":"suppl 10","key":"R3-20250912","first-page":"S108","article-title":"Optimizing antibiotic drug therapy in pediatrics: current state and future needs","volume":"58","author":"Le","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"R4-20250912","first-page":"Cd005179","article-title":"Psychological interventions for needle-related procedural pain and distress in children and adolescents","volume":"10","author":"Birnie","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-20250912","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/apa.14607","article-title":"Blood draws up to 3% of blood volume in clinical trials are safe in children","volume":"108","author":"Peplow","year":"2019","journal-title":"Acta Paediatr"},{"key":"R6-20250912","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/cpt.2202","article-title":"From therapeutic drug monitoring to model-informed precision dosing for antibiotics","volume":"109","author":"Wicha","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"R7-20250912","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/jac\/dkab048","article-title":"AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatrics","volume":"76","author":"Jorgensen","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"R8-20250912","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fphar.2020.00794","article-title":"Individualized dosing with high inter-occasion variability is correctly handled with model-informed precision dosing using rifampicin as an example","volume":"11","author":"Keutzer","year":"2020","journal-title":"Front Pharmacol"},{"key":"R9-20250912","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2014.05.016","article-title":"Innovative approaches to optimizing the delivery of vancomycin in individual patients","volume":"77","author":"Pai","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"R10-20250912","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01086153","article-title":"Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients","volume":"4","author":"Sawchuk","year":"1976","journal-title":"J Pharmacokinet Biopharm"},{"key":"R11-20250912","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/INF.0b013e318286378e","article-title":"Improved vancomycin dosing in children using area under the curve exposure","volume":"32","author":"Le","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20250912","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/B:JOPA.0000029490.76908.0c","article-title":"A Bayesian approach to tracking patients having changing pharmacokinetic parameters","volume":"31","author":"Bayard","year":"2004","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R13-20250912","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40262-012-0020-y","article-title":"Benchmarking therapeutic drug monitoring software: a review of available computer tools","volume":"52","author":"Fuchs","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"R14-20250912","first-page":"95","article-title":"Modeling, adaptive control, and optimal drug therapy","volume":"16","author":"Jelliffe","year":"1990","journal-title":"Med Prog Technol"},{"key":"R15-20250912","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.ccm.0000908940.54979.b5","article-title":"803: a pilot study evaluating midpoint vancomycin concentrations to estimate area under the curve","volume":"51","author":"Nazer","year":"2023","journal-title":"Crit Care Med"},{"key":"R16-20250912","doi-asserted-by":"crossref","first-page":"241","DOI":"10.29090\/psa.2024.03.24.AP0723","article-title":"Population pharmacokinetic modeling and convenient sampling of midpoint concentration for therapeutic drug monitoring of vancomycin in Vietnamese pediatric patients","volume":"51","author":"Hai","year":"2024","journal-title":"Pharm Sci Asia"},{"key":"R17-20250912","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/psp4.12689","article-title":"Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayr","volume":"10","author":"Le Louedec","year":"2021","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"R18-20250912","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/psp4.12467","article-title":"Quantitative systems pharmacology and physiologically-based pharmacokinetic modeling with mrgsolve: a hands-on tutorial","volume":"8","author":"Elmokadem","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"R19-20250912","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/pharmaceutics11050224","article-title":"Application of pharmacometrics in pharmacotherapy: open-source software for vancomycin therapeutic drug management","volume":"11","author":"Bae","year":"2019","journal-title":"Pharmaceutics"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T12:02:18Z","timestamp":1757678538000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001323","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"2024-09-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}